Amir Landi

Abdolamir Landi, MD, PhD, also known as, Amir Landi, is a senior research scientist and principal investigator in the Department of Medical Microbiology and Immunology at the University of Alberta, Canada. He serves as a member of the ME/CFS committee of the Alberta Medical Association and a Research and Medical Advisor to National ME/FM Action Network, Canada. He has been working on the immunologic aspects of ME/CFS since 2010.

Dr. Landi leads the biomarker team in Professor Michael Houghton's laboratory in the Department of Medical Microbiology and Immunology at the University of Alberta, Canada, working to validate a panel of cytokine biomarkers for ME/CFS.

Dr. Landi is a scientific member of the executive committee and the chair of the working group Infection & Immunity of Interdisciplinary Canadian Collaborative ME (ICanCME) Research Network. | last4

Education

 * 1995, MD - Tehran University of Medical Sciences, Iran
 * 2009, PhD - Immunovirology / Vaccinology from University of Saskatchewan, Canada
 * 2010, post-doctorate fellowship - Vaccine and Infectious Disease Organization, International Vaccine Centre, Saskatoon, Saskatchewan, Canada
 * 2015, post-doctorate fellowship - University of Alberta, Edmonton, Alberta, Canada

Clinical care guidelines

 * 2016, Toward Optimized Practice (TOP) ME/CFS Clinical Practice Guidelines

Patents

 * 2019, Methods and compositions in diagnosis of chronic fatigue syndrome/myalgic encephalomyelitis. US Patent: 10,408,844. The patent is for two assay algorithms of specific cytokines and chemokines for a serologic diagnostic test for CFS/ME. Inventors: Abdolamir Landi, David Broadhurst,D. Lorne J. Tyrrell, Michael Houghton

Research studies

 * 2011, No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndrome - (Full text)
 * 2016, Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome - (Full text)

Talks and interviews

 * 27-30 May 2015, Biomedical Research into ME Colloquium (BRMEC5), London, UK - Speech title: Cytokine and Chemokine Profiles of ME/CFS Patients.
 * 3-5 May 2018, ME/CFS Canadian Collaborative Team Conference, Montreal, Canada - Speech title: Diagnosis of ME/CFS: Can Immune Modulators Play a Role?
 * 14 & 15 Dec. 2018, CIHR ME/CFS Strengthening Workshop, Montreal, Canada - Speech title: Immunobiology of ME/CFS: From pathogen discovery to pathogenesis.
 * 24 October 2019, Canadian CBC Radio, Morning Episodes
 * 28 October 2019, Canadian Global NEWS Edmonton TV interview: Global News, Health Matters

Online presence

 * LinkedIn


 * ResearchGate